September 2019
PediaVascular held its second annual product pitch competition during the Pediatric & Adult Interventional Cardiac Symposium on September 6, in San Diego. Six teams of pediatric cardiologists presented their concepts to a panel of interventional cardiology experts. The winning concept was by Marin Bock from Rainbow Babies Hospital and titled Bioresorbable ASD Occulder. PediaVascular awarded Dr. Bocks an unrestricted $25,000 grant to continue development efforts. As with the previous award he will also receive complementary consultations with regulatory, reimbursement, intellectual property, legal and business experts to assist in product commercialization.
Tim Moran and Martin Bocks, MD
September 2018
Recognizing the lack of funding for pediatric medical device development, PediaVascular held a product pitch competition during the Pediatric & Adult Interventional Cardiac Symposium on September 6, in Las Vegas. Five teams of pediatric cardiologists presented their concepts to a panel of interventional cardiology experts. The winning concept was titled Deflectable Hybrid Sheath from a team at Our Lady’s Children’s Hospital, Crumlin, Ireland. PediaVascular awarded the team an unrestricted $25,000 grant to continue development efforts. The award also included complementary consultations with regulatory, reimbursement, intellectual property, legal and business experts to assist in product commercialization.
Tim Moran, Damien Kenny MD, Kevin Walsh MD, Brian Bailey
February 2017
PediaVascular has seucred CE marking and has begun a European-wide product launch.
October 2015
PediaVascular estimates that physicians now have treated over 10,000 babies with its devices.
May 2013
The New York Times discusses the first use of the Mongoose Pediatric Catheter. New York Time Article
September 2012
PediaVascular secures 510k clearance for Super Sheath introducer sheaths, the first and only introducer sheaths to receive a pediatric indication for use from the FDA.
July 2012
PediaVascular secures 510k clearance for Mongoose angiography catheters, the first and only angiography catheters to receive a pediatric indication for use from the FDA.
July, 2010
PediaWorks announced the formation of PediaVascular, Inc., a social venture to help alleviate the severe shortage of medical devices for use in pediatric patients.
PediaVascular will be the first and only organization to develop catheters just for children. For decades the lack of financial incentives has hampered the development of pediatric-specific medical devices. As a result physicians are often limited in the therapies they can deliver to children.
According to U.S. Senator Sherrod Brown. “Too often, medical devices are not made with children in mind. Because of the unique set of circumstances that discourage innovation in pediatric medical research and development, thinking outside the box becomes a necessity. This important new venture does just that. This initiative will help ensure that our children have the right medical devices designed for their growing bodies and further cement Cleveland as a hub for medical research and development.”